Not applicableStudy completedNCT00661284
What this trial is testing
Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)
Who this might be right for
Rheumatoid Arthritis
Chugai Pharmaceutical 189